Navigation Links
Patients to benefit from novel technology revolutionizing high-speed molecular imaging

The new technologically advanced D-SPECT camera enables shorter image acquisition times, provides better image quality and opens the door to new diagnostic procedures using simultaneous multi-isotope imaging--providing the potential to revolutionize functional imaging, according to results released at SNM's 53rd Annual Meeting June 3? in San Diego.

"The potential of using more than one tracer and more than one isotope simultaneously means that more than one medical condition can be searched in one go--ultimately improving the diagnosis of cancer, heart and brain diseases," explained James A. Patton, professor of radiology and physics with the department of radiology and radiological sciences at Vanderbilt University Medical Center in Nashville, Tenn. "In addition, as the speed of this new D-SPECT camera approaches the imaging speed of computed tomography (CT), it will become economical to have functional and anatomic imaging in line (as a hybrid image) and in near real time for developing combined single photon emission computerized tomography (SPECT) and CT images," added the co-author of "D-SPECT: A New Solid State Camera for High-Speed Molecular Imaging."

"Patient health considerations and radiation safety standards limit the radiation dose that can be administered for the purpose of diagnostic imaging," said Patton. "In addition to this limitation, the low efficiency of existing SPECT imaging technology in collecting radiation imposes very long acquisition times of up to a full hour and sometimes more," he added. "This new camera technology enables acquisition times that are shorter by an order of magnitude (2 minutes vs. today's 20 minutes for a cardiac scan), better image quality (up to two times the image resolution) and the potential for new diagnostic procedures employing simultaneous multi-isotope imaging for more versatile diagnostics," he explained. "Due to its very high sensitivity (10 times higher) and definition (up to 2 times the re
'"/>

Source:Society of Nuclear Medicine


Page: 1 2 3

Related biology news :

1. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
2. HIV Patients May Be at Risk of Heart Problems When Taking Protease Inhibitor Drugs
3. Emory Eye Center Implants Its First Retinal Chips In Patients With Retinitis Pigmentosa
4. Implanted Devices Detect High-Risk Heart Failure Patients
5. Rush Physicians Using Gene Therapy For Heart Patients With Moderate To Severe Chest Pains Who Do Not Benefit From Other Treatments
6. Gene Signatures Predict Interferon Response For Multiple Sclerosis Patients
7. Bevacizumab Combined With Chemotherapy Improves Progression-Free Survival for Patients With Advanced Breast Cancer
8. Single-donor Islet Transplantation Procedure Shows Promise For Patients With Type 1 Diabetes
9. IMF Launches World’s First DNA Database for Myeloma Patients
10. Patients now surviving once-fatal immune disease
11. Patients and their doctors have different perceptions about HIV and its treatment

Post Your Comments:
(Date:11/24/2009)...(LRI) today named 12 new grant recipients for 2009...ovative work across a broad spectrum of lupus rese...lty, and potential to drive scientific discovery t...disease of systemic lupus. , The 2009 grants go ...ss the nation and include interdisciplinary and hi...
(Date:11/24/2009)...a protein that may help gut bacteria bind to the g...y probiotic producers to identify strains that are...otics need to interact with cells lining the gut t...surfaces in the gut they are more likely to stick ...Dr Nathalie Juge from the Institute of Food Resear...
(Date:11/24/2009)...remarkable class of ring-shaped protein motors has...erkeley National Laboratory (Berkeley Lab) using a... at the Advanced Light Source (ALS). These protein...replication, and are vital to the survival of all ...ch as the human papillomavirus, which has been lin...
Breaking Biology News(10 mins):Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3A sticky solution for identifying effective probiotics 2Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Syngenta Licenses Chromatin Gene Stacking Technology for Sugar Cane 12800 1Syngenta Licenses Chromatin Gene Stacking Technology for Sugar Cane 12800 2Syngenta Licenses Chromatin Gene Stacking Technology for Sugar Cane 12800 3Register to Win a Ski Weekend and Make Your Synthesis Easier with EasyMax 26amp 3B 238482 3B 3A the First Automated Chemistry Development Tool That Re 12796 1Register to Win a Ski Weekend and Make Your Synthesis Easier with EasyMax 26amp 3B 238482 3B 3A the First Automated Chemistry Development Tool That Re 12796 2HealthSource of Chicago 3A New Techniques for Back Pain Relief in Chicago 50144 1HealthSource of Chicago 3A New Techniques for Back Pain Relief in Chicago 50144 2HealthSource of Chicago 3A New Techniques for Back Pain Relief in Chicago 50144 3HealthSource of Chicago 3A New Techniques for Back Pain Relief in Chicago 50144 4
..., Professor of Molecular Biophysics and Biochemist...gh Research Institute Award. , The award is given... Biology to recognize outstanding scientific contr...careers. , Strobel will give the award lecture, t...osomes, and Riboswitches, at the societys annual m...
...lobal Innovation Imperatives (Gii) project swung i... first session at the American Chemical Societys (... joint collaboration between the ACS Committee on ... Industry, seeks to combat worldwide health, envir...-based solutions, particularly those relating to c...
...nt of the children in the U.S. carry backpacks. Ty...ourth of the childs body weight (22 percent) and w...sician researchers examined the effect heavy-loade... the straps can significantly increase pressure wh...d that strap pressures with loads as small as ten ...
Other Biology News:Yale University's Strobel recognized for work on RNA 2At ACS' national meeting, global initiative set to tackle water issues 2Backpack straps can decrease blood flow in the shoulder and arm 2
(Date:11/30/2009)...STERDAM, November 30 Els..., medical and technical products and services,tod...rehensive biomedical,database which holds over 20 ...e, peer reviewed journals. , Embase has l...omedical,and pharmaceutical insights. Now, new dev...
(Date:11/27/2009)...ire-FirstCall/ -- Stallergenes has been,granted Eu...s and children,through a Mutual Recognition Proced...as been marketed, was the reference Member state. ..., Belgium, Bulgaria, Cyprus, the,Czech Republic, E... Italy,Latvia, Lithuania, Luxembourg, Malta, the ...
(Date:11/25/2009)...re/ -- Biotech firm Replikins Ltd., which has anal...ndemic through the prediction, outbreak, and progr... latest biochemical analysis of the virus. The new... Flu") virus has dropped from its peak of 3.7 (s.d...spring of 2009 to resting non-epidemic levels this...
(Date:11/25/2009)...Newswire-Asia/ -- Sinovac Biotech Ltd. ( SVA),a l...ed today that it executed,a joint venture (JV) agr...ology Co., Ltd. (Sinovac Dalian). The JV will rese... vaccines. Sinovac will contribute its expertise,a...rld-class vaccines; the,other party will bring its...
Breaking Biology Technology:Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 2Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 3STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 2STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 3Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3
...Q3 Results, FRANKLIN, Mass., Nov. 20 Echo Therap...nced financial results for the,third quarter ended...er 30,2007, net loss was $8,677,000 or $.70 per sh... the same period in 2006. For the nine months ende... $1.05 per share, compared,to $4,229,000 or $1.60 ...
...mentation Technology, Ser...ris has been selected as,the first awarded supplie...,by Provista, one of the nation,s leading group pu...nt, Spheris will provide Provista customers with,a... in addition to,industry-leading outsource service...
...ia E to be Featured, HOFFMAN ESTATES, Ill., Nov. ...r additions to existing,technology, Siemens Medica... is,propelling the field of molecular medicine to ...ing oncology, neurology and cardiology, Siemens wi...nologies at the 93rd,Scientific Assembly and Annua...
Other Biology Technology:Echo Therapeutics Reports Third Quarter 2007 Results 2Echo Therapeutics Reports Third Quarter 2007 Results 3Echo Therapeutics Reports Third Quarter 2007 Results 4Echo Therapeutics Reports Third Quarter 2007 Results 5Echo Therapeutics Reports Third Quarter 2007 Results 6Provista Awards Agreement to Spheris 2Delivering Molecular Imaging Solutions Across Clinical Specialties: Siemens Showcases New Technologies at RSNA 2007 2Delivering Molecular Imaging Solutions Across Clinical Specialties: Siemens Showcases New Technologies at RSNA 2007 3Delivering Molecular Imaging Solutions Across Clinical Specialties: Siemens Showcases New Technologies at RSNA 2007 4Delivering Molecular Imaging Solutions Across Clinical Specialties: Siemens Showcases New Technologies at RSNA 2007 5
Anti-AANAT Antibody, Unconjugated from CHEMICON
Mouse Anti-TUP1 Monoclonal Antibody, Unconjugated, Clone 10 from Exalpha Biologicals, Inc.
Mouse Anti-Human NANS Monoclonal Antibody, Unconjugated, Clone 3G6 from ABR-Affinity BioReagents
Mouse Anti-C2 Monoclonal Antibody, Unconjugated, Clone 050-04 from Abcam
Biology Products: